Aurora Cannabis Inc. ($ACB) Stock Forecast: Up 5.1% Today

What is Aurora Cannabis Inc.?

Aurora Cannabis Inc. (ACB) is a leading Canadian cannabis company known for its global medical cannabis presence. The stock had a bullish movement today amidst recent market activities.

Why is Aurora Cannabis Inc. going up?

ACB stock is up 5.1% on Aug 8, 2025 14:42

• ACB stock experienced a strong bullish movement despite Q1 earnings missing estimates, showcasing resilience in the face of challenges.
• The 17.5% year-over-year revenue growth indicates the company's ability to capitalize on the strong global medical cannabis demand.
• Investors seem optimistic about ACB's future potential, as the stock beat revenue estimates despite reporting a loss, hinting at long-term growth prospects.
• Despite near-term regulatory headwinds impacting Q1 revenue, ACB's solid global medical cannabis momentum suggests a promising outlook for the stock.

ACB Price Chart

ACB Technical Analysis

ACB News

ACB Stock Down as Q1 Earnings Miss Estimates, Revenues Up Y/Y

Aurora Cannabis stock slips after Q1 earnings miss, but revenue climbs 17.5% year over year on strong global medical cannabis demand.

https://www.zacks.com/stock/news/2674173/acb-stock-down-as-q1-earnings-miss-estimates-revenues-up-yy

Aurora Cannabis Inc. ( ACB ) Reports Q1 Loss, Beats Revenue Estimates

Aurora Cannabis (ACB) delivered earnings and revenue surprises of -205.56% and +6.50%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2672734/aurora-cannabis-inc-acb-reports-q1-loss-beats-revenue-estimates

Aurora Cannabis Pre-Q1 Earnings Analysis: Buy, Sell or Hold the Stock?

ACB's global medical cannabis momentum stays strong, but near-term regulatory headwinds might have limited Q1 revenue upside.

https://www.zacks.com/stock/news/2661494/aurora-cannabis-pre-q1-earnings-analysis-buy-sell-or-hold-the-stock

Trending Today

Soybeans ($SOY) Commodity Forecast: Up 1.5% Today

Aurora Cannabis Inc. Price History

18.05.2025 - ACB Stock was down 22.7%

• The decline in ACB stock is linked to lower-than-expected demand in the global market, evident from the Q4 earnings missing estimates.
• Despite improved adjusted EBITDA and global medical cannabis net revenue, the market reacted negatively due to reported quarterly loss per share.
• The stock fall during pre-market trading, dropping by 20.1% post fourth-quarter results, added to the negative sentiment surrounding ACB.
• Concerns about future growth and operational efficiency are likely driving investor worries, contributing to the downward trend in ACB stock.

04.05.2025 - ACB Stock was up 5.3%

• Recommendation by a notable financial commentator favoring Nvidia over Aurora Cannabis potentially influenced investors to shift focus towards the semiconductor industry, positively impacting ACB's stock.
• The upward trend in ACB's stock value could also be linked to investors seeking growth prospects in the cannabis sector amid evolving regulations and growing market demand.
• The optimistic outlook on ACB may be fueled by market participants anticipating robust financial performance or strategic partnerships in the future, leading to an increase in the stock price.

25.01.2025 - ACB Stock was down 5.3%

• Analysts foresee a 25.67% upside in ACB stock, potentially influencing bullish sentiment among investors.
• Market response may have been bearish given the disparity between analyst projections and the company's actual performance.
• Investor caution regarding industry volatility and regulatory uncertainties could be weighing negatively on ACB's stock.
• The gap between analyst optimism and market performance may have prompted profit-taking and a bearish trend in ACB stock.

20.02.2025 - ACB Stock was up 6.0%

• The bullish movement in ACB's stock today is possibly linked to the favorable sentiment surrounding the global legalization of cannabis, positioning the company well to benefit from this trend.
• A comparison with Concentra Group suggests that ACB is excelling within the medical stocks sector, potentially enhancing investor confidence in the stock.
• ACB's extensive regulatory expertise and robust manufacturing capabilities likely played a part in its strong performance, attracting investors interested in the expanding medical cannabis market.

20.02.2025 - ACB Stock was up 7.5%

• ACB's bullish movement today can be attributed to the discovery of a new source of genetic resistance against powdery mildew in cannabis sativa, showcasing the company's commitment to innovation and product development.
• The company's strategic positioning in the rapidly evolving medical cannabis landscape, with EU GMP-certified manufacturing facilities and advanced genetics, has also contributed to investor confidence and interest in ACB.
• As the global legalization wave for cannabis continues to gain momentum, ACB's strong performance and focus on developing powdery mildew-resistant plants further solidify its position as a key player in the industry, attracting potential investors seeking growth opportunities in the sector.

06.07.2025 - ACB Stock was down 5.6%

• The bearish movement in ACB today could be attributed to the near-term regulatory headwinds mentioned in the pre-Q1 earnings analysis, which may have limited revenue upside for the company.
• Options market movements might indicate that traders are anticipating further downside in ACB stock, leading to increased selling pressure.
• Investors are likely cautious about the regulatory challenges and potential revenue constraints facing Aurora Cannabis, prompting them to consider selling or holding their positions rather than buying more shares at the moment.

06.07.2025 - ACB Stock was down 7.5%

• Despite surpassing revenue estimates, Aurora Cannabis Inc. (ACB) reported a significant loss in Q1, leading to a decline in the stock price.
• The company's strong global medical cannabis momentum was impacted by short-term regulatory obstacles, affecting its revenue performance in the quarter.
• Market options indicate that investors are attentively watching ACB stock, reflecting possible uncertainty and caution regarding the company's future.
• The combination of underwhelming financial results and regulatory hurdles likely contributed to the bearish market movement of Aurora Cannabis Inc. (ACB) today.

10.01.2025 - ACB Stock was up 7.4%

• Aurora Cannabis (ACB) stock saw a remarkable 45% increase following its strong performance in Q3. The report highlighted impressive medical cannabis sales and robust financial results.
• Surpassing analyst expectations by 50% in earnings and 9.50% in revenue, the company's earnings report instilled confidence in investors, propelling the stock price upwards.
• Positive market sentiment within the cannabis industry was reinforced by a recent development involving a delay in U.S. tariffs on Canadian goods, further elevating ACB's success.
• Aurora's strategic focus on efficiency, cost-cutting measures, and heightened gross margins also significantly influenced the market's positive response, hinting at a potential resurgence for the company in the competitive cannabis market.

27.01.2025 - ACB Stock was down 5.9%

• The decline in ACB stock today may be due to investors taking profits following a period of gains.
• Analysts have a positive outlook on ACB's future performance, estimating a potential upside of 25.67% according to Wall Street projections.
• The discrepancy between the stock's decline and analysts' optimistic forecasts suggests short-term market trends rather than lingering concerns over the company's prospects.
• Given the volatility of the cannabis industry, investors are advised to monitor regulatory updates and market shifts when considering investments in ACB stock.

17.02.2025 - ACB Stock was up 5.3%

• ACB's upward movement may be linked to positive internal developments like robust financial results and strategic collaborations.
• In comparison with Concentra Group (CON), ACB's strong performance in the medical segment could be enhancing investor sentiment towards the stock.
• The optimistic trajectory of ACB reflects the increasing confidence in the cannabis sector, leading to a rise in stock values industry-wide.

08.07.2025 - ACB Stock was up 5.1%

• ACB stock experienced a strong bullish movement despite Q1 earnings missing estimates, showcasing resilience in the face of challenges.
• The 17.5% year-over-year revenue growth indicates the company's ability to capitalize on the strong global medical cannabis demand.
• Investors seem optimistic about ACB's future potential, as the stock beat revenue estimates despite reporting a loss, hinting at long-term growth prospects.
• Despite near-term regulatory headwinds impacting Q1 revenue, ACB's solid global medical cannabis momentum suggests a promising outlook for the stock.

18.05.2025 - ACB Stock was down 19.3%

• ACB stock experienced a significant bearish movement of 20.1% in pre-market trading.
• The fourth-quarter results of Aurora Cannabis showed a quarterly loss of 24 cents per share, which disappointed investors.
• The negative earnings report likely contributed to the sharp decline in ACB stock price as investors reacted to the company's financial performance.
• The overall bearish sentiment in the market could have also played a role in the downward movement of ACB stock.